A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).
Y. Katsura
Shogo Kobayashi
Yutaka Takeda
Yoshiaki Ohmura
Hidenori Takahashi
T. Asaoka
Y. Iwagami
S. Nakahira
Junzo Shimizu
Y. Doki
H. Eguchi
Medicine